SARS-COV-2 infection in a patient with Evans syndrome: A silent enemy or an ally?
Introduction. During the current outbreak of Coronavirus disease 2019 (COVID-19), the way to manage patients with autoimmune diseases remains elusive due to limited data available. Case report. We presented a case of a COVID-19 positive 20-year-old female with prior history of Evans syndrome. The pa...
Main Authors: | Pantić Nikola, Mitrović Mirjana, Virijević Marijana, Sabljić Nikica, Pravdić Zlatko, Suvajdžić Nada |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2020-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84502000115P.pdf |
Similar Items
-
Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy
by: VA Shuvaev, et al.
Published: (2017-10-01) -
Evans syndrome in children. Long-term outcome in a prospective French national observational cohort.
by: Nathalie eAladjidi, et al.
Published: (2015-09-01) -
A strange case of Evans syndrome
by: Manuel Monti, et al.
Published: (2013-12-01) -
Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01) -
Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia
by: Perdomo J
Published: (2016-02-01)